Advertisement

Acutely decompensated heart failure with chronic obstructive pulmonary disease: Clinical characteristics and long-term survival

Published:November 13, 2018DOI:https://doi.org/10.1016/j.ejim.2018.11.002

      Highlights

      • Chronic obstructive pulmonary disease (COPD) is a common comorbidity in acute heart failure.
      • Comorbid COPD entailed an increased risk of long-term mortality.
      • Most of the excess mortality occurred in the first few months following hospitalization.
      • β-blockers reduced the risk of death in patients with comorbid COPD.

      Abstract

      Background

      Chronic obstructive pulmonary disease (COPD) is among the most common comorbidities in patients hospitalized with heart failure and is generally associated with poor outcomes. However, the results of previous studies with regard to increased mortality and risk trajectories were not univocal. We sought to assess the prognostic impact of COPD in patients admitted for acutely decompensated heart failure (ADHF) and investigate the association between use of β-blockers at discharge and mortality in patients with COPD.

      Methods

      We studied 1530 patients. The association of COPD with mortality was examined in adjusted Fine-Gray proportional hazard models where heart transplantation and ventricular assist device implantation were treated as competing risks. The primary outcome was 5-year all-cause mortality.

      Results

      After adjusting for establisked risk markers, the subdistribution hazard ratios (SHR) of 5-year mortality for COPD patients compared with non-COPD patients was 1.25 (95% confidence intervals [CIs] 1.06–1.47; p = .007). The relative risk of death for COPD patients increased steeply from 30 to 180 days, and remained noticeably high throughout the entire follow-up. Among patients with comorbid COPD, the use of β-blockers at discharge was associated with a significantly reduced risk of 1-year post-discharge mortality (SHR 0.66, 95%CIs 0.53–0.83; p ≤.001).

      Conclusions

      Our data indicate that ADHF patients with comorbid COPD have a worse long-term survival than those without comorbid COPD. Most of the excess mortality occurred in the first few months following hospitalization. Our data also suggest that the use of β-blockers at discharge is independently associated with improved survival in ADHF patients with COPD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Global Burden of Disease Study 2013 Collaborators
        Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.
        Lancet. 2015; 386: 743-800
        • Benjamin E.J.
        • Blaha M.J.
        • Chiuve S.E.
        • Cushman M.
        • Das S.R.
        • Deo R.
        • et al.
        Heart disease and stroke statistics-2017 update: a report from the American Heart Association.
        Circulation. 2017; 135: e146-e603https://doi.org/10.1161/CIR.0000000000000485
        • van der Wal M.H.
        • Jaarsma T.
        • Moser D.K.
        • Veeger N.J.
        • van Gilst W.H.
        • van Veldhuisen D.J.
        Compliance in heart failure patients: the importance of knowledge and beliefs.
        Eur Heart J. 2006; 27: 434-440
        • Adeloye D.
        • Chua S.
        • Lee C.
        • Basquill C.
        • Papana A.
        • Theodoratou E.
        • et al.
        Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.
        J Glob Health. 2015; 5020415https://doi.org/10.7189/jogh.05-020415
        • Ambrosy A.P.
        • Fonarow G.C.
        • Butler J.
        • Chioncel O.
        • Greene S.J.
        • Vaduganathan M.
        • et al.
        The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.
        J Am Coll Cardiol. 2014; 63: 1123-1133
        • Maggioni A.P.
        • Dahlström U.
        • Filippatos G.
        • Chioncel O.
        • Crespo Leiro M.
        • Drozdz J.
        • et al.
        EURObservational research programme: the heart failure pilot survey (ESC-HF pilot).
        Eur J Heart Fail. 2010; 12: 1076-1084
        • Chioncel O.
        • Mebazaa A.
        • Harjola V.P.
        • Coats A.J.
        • Piepoli M.F.
        • Crespo-Leiro M.G.
        • et al.
        Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart failure Long-Term Registry.
        Eur J Heart Fail. 2017; 19: 1242-1254
        • Störk S.
        • Handrock R.
        • Jacob J.
        • Walker J.
        • Calado F.
        • Lahoz R.
        • et al.
        Epidemiology of heart failure in Germany: a retrospective database study.
        Clin Res Cardiol. 2017; 106: 913-922
        • Ponikowski P.
        • Voors A.A.
        • Anker S.D.
        • Bueno H.
        • Cleland J.G.
        • Coats A.J.
        • et al.
        2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
        Eur Heart J. 2016; 37: 2129-2200
        • Di Lenarda A.
        • Scherillo M.
        • Maggioni A.P.
        • Acquarone N.
        • Ambrosio G.B.
        • Annicchiarico M.
        • et al.
        Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study.
        Am Heart J. 2003; 146E12
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey Jr., D.E.
        • Drazner M.H.
        • et al.
        2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
        Circulation. 2013; 128: e240-e327https://doi.org/10.1161/CIR.0b013e31829e8776
        • Dharmarajan K.
        • Hsieh A.F.
        • Kulkarni V.T.
        • Lin Z.
        • Ross J.S.
        • Horwitz L.I.
        • et al.
        Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study.
        BMJ. 2015; 350: h411https://doi.org/10.1136/bmj.h411
        • Hawkins N.M.
        • Petrie M.C.
        • Jhund P.S.
        • Chalmers G.W.
        • Dunn F.G.
        • McMurray J.J.
        Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology.
        Eur J Heart Fail. 2009; 11: 130-139
        • Čelutkienė J.
        • Balčiūnas M.
        • Kablučko D.
        • Vaitkevičiūtė L.
        • Blaščiuk J.
        • Danila E.
        Challenges of treating acute heart failure in patients with chronic obstructive pulmonary disease.
        Card Fail Rev. 2017; 3: 56-61
        • Bhatt S.P.
        • Dransfield M.T.
        Chronic obstructive pulmonary disease and cardiovascular disease.
        Transl Res. 2013; 162: 237-251
        • Dharmarajan K.
        • Strait K.M.
        • Tinetti M.E.
        • Lagu T.
        • Lindenauer P.K.
        • Lynn J.
        • et al.
        Treatment for multiple acute cardiopulmonary conditions in older adults hospitalized with pneumonia, chronic obstructive pulmonary disease, or heart failure.
        J Am Geriatr Soc. 2016; 64: 1574-1582
        • Staszewsky L.
        • Cortesi L.
        • Tettamanti M.
        • Dal Bo G.A.
        • Fortino I.
        • Bortolotti A.
        • et al.
        Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
        Eur J Heart Fail. 2016; 18: 840-848
        • Mentz R.J.
        • Schmidt P.H.
        • Kwasny M.J.
        • Ambrosy A.P.
        • O'Connor C.M.
        • Konstam M.A.
        • et al.
        The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial.
        J Card Fail. 2012; 18: 515-523
        • Mentz R.J.
        • Fiuzat M.
        • Wojdyla D.M.
        • Chiswell K.
        • Gheorghiade M.
        • Fonarow G.C.
        • et al.
        Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
        Eur J Heart Fail. 2012; 14: 395-403
        • Canepa M.
        • Straburzynska-Migaj E.
        • Drozdz J.
        • Fernandez-Vivancos C.
        • Pinilla J.M.G.
        • Nyolczas N.
        • et al.
        Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
        Eur J Heart Fail. 2018; 20: 100-110
        • Macchia A.
        • Monte S.
        • Romero M.
        • D'Ettorre A.
        • Tognoni G.
        The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure.
        Eur J Heart Fail. 2007; 9: 942-948
        • Agoston I.
        • Cameron C.S.
        • Yao D.
        • Dela R.A.
        • Mann D.L.
        • Deswal A.
        Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction.
        Am J Cardiol. 2004; 94: 1003-1007
        • Lee D.S.
        • Austin P.C.
        • Rouleau J.L.
        • Liu P.P.
        • Naimark D.
        • Tu J.V.
        Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.
        JAMA. 2003; 290: 2581-2587
        • Senni M.
        • Santilli G.
        • Parrella P.
        • De Maria R.
        • Alari G.
        • Berzuini C.
        • et al.
        A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure.
        Am J Cardiol. 2006; 98: 1076-1082
        • Jong P.
        • Vowinckel E.
        • Liu P.P.
        • Gong Y.
        • Tu J.V.
        Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study.
        Arch Intern Med. 2002; 162: 1689-1694
        • Scrutinio D.
        • Ammirati E.
        • Guida P.
        • Passantino A.
        • Raimondo R.
        • Guida V.
        • et al.
        Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
        Int J Cardiol. 2013; 168: 2120-2126
        • Rusinaru D.
        • Saaidi I.
        • Godard S.
        • Mahjoub H.
        • Battle C.
        • Tribouilloy C.
        Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure.
        Am J Cardiol. 2008; 101: 353-358
        • Siirila-Waris K.
        • Lassus J.
        • Melin J.
        • Peuhkurinen K.
        • Nieminen M.S.
        • Harjola V.P.
        Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
        Eur Heart J. 2006; 27: 3011-3017
        • Lainscak M.
        • Hodoscek L.M.
        • Düngen H.D.
        • Rauchhaus M.
        • Doehner W.
        • Anker S.D.
        • et al.
        The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.
        Wien Klin Wochenschr. 2009; 121: 309-313
        • Parissis J.T.
        • Andreoli C.
        • Kadoglou N.
        • Ikonomidis I.
        • Farmakis D.
        • Dimopoulou I.
        • et al.
        Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.
        Clin Res Cardiol. 2014; 103: 733-741
        • Fisher K.A.
        • Stefan M.S.
        • Darling C.
        • Lessard D.
        • Goldberg R.J.
        Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the worcester Heart failure Study.
        Chest. 2015; 147: 637-645
        • Krumholz H.M.
        • Wang Y.
        • Mattera J.A.
        • Wang Y.
        • Han L.F.
        • Ingber M.J.
        • et al.
        An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure.
        Circulation. 2006; 113: 1693-1701
        • Pokorney S.D.
        • Al-Khatib S.M.
        • Sun J.L.
        • Schulte P.
        • O'Connor C.M.
        • Teerlink J.R.
        • et al.
        Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
        Eur J Heart Fail. 2018; 20: 525-532
        • O'Kelly N.
        • Robertson W.
        • Smith J.
        • Dexter J.
        • Carroll-Hawkins C.
        • Ghosh S.
        Short-term outcomes in heart failure patients with chronic obstructive pulmonary disease in the community.
        World J Cardiol. 2012; 4: 66-71
        • Londoño K.L.
        • Formiga F.
        • Chivite D.
        • Moreno-Gonzalez R.
        • De Amicis M.M.
        • Corbella X.
        Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for their first episode of acute heart failure.
        Intern Emerg Med. 2018; 13: 351-357
        • Jacob J.
        • Tost J.
        • Miró Ò.
        • Herrero P.
        • Martín-Sánchez F.J.
        • Llorens P.
        • et al.
        Impact of chronic obstructive pulmonary disease on clinical course after an episode of acute heart failure. EAHFE-COPD study.
        Int J Cardiol. 2017; 227: 450-456
        • Lipworth B.
        • Skinner D.
        • Devereux G.
        • Thomas V.
        • Ling Zhi Jie J.
        • Martin J.
        • et al.
        Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
        Heart. 2016; 102: 1909-1914
        • Wolbers M.
        • Koller M.T.
        • Stel V.S.
        • Schaer B.
        • Jager K.J.
        • Leffondré K.
        • et al.
        Competing risks analyses: objectives and approaches.
        Eur Heart J. 2014; 35: 2936-2941
        • Austin P.C.
        • Lee D.S.
        • Fine J.P.
        Introduction to the analysis of survival data in the presence of competing risks.
        Circulation. 2016; 133: 601-609
        • Ouwerkerk W.
        • Voors A.A.
        • Zwinderman A.H.
        Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure.
        JACC Heart Fail. 2014; 2: 429-436
        • Rahimi K.
        • Bennett D.
        • Conrad N.
        • Williams T.M.
        • Basu J.
        • Dwight J.
        • et al.
        Risk prediction in patients with heart failure: a systematic review and analysis.
        JACC Heart Fail. 2014; 2: 440-446
        • Mortara A.
        • Oliva F.
        • Metra M.
        • Carbonieri E.
        • Di Lenarda A.
        • Gorini M.
        • et al.
        Treatment with inotropes and related prognosis in acute heart failure: contemporary data from the Italian Network on Heart Failure (IN-HF) Outcome registry.
        J Heart Lung Transplant. 2014; 33: 1056-1065
        • Casanova C.
        • de Torres J.P.
        • Aguirre-Jaíme A.
        • Pinto-Plata V.
        • Marin J.M.
        • Cordoba E.
        • et al.
        The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
        Am J Respir Crit Care Med. 2011; 184: 1015-1021
        • Dickstein K.
        • Cohen-Solal A.
        • Filippatos G.
        • McMurray J.J.
        • Ponikowski P.
        • Poole-Wilson P.A.
        • et al.
        ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
        Eur Heart J. 2008; 29: 2388-2442
        • Vestbo J.
        • Hurd S.S.
        • Agustí A.G.
        • Jones P.W.
        • Vogelmeier C.
        • Anzueto A.
        • et al.
        Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
        Am J Respir Crit Care Med. 2013; 187: 347-365
        • Cohen Solal A.
        • Leurs I.
        • Assyag P.
        • Beauvais F.
        • Clerson P.
        • Contre C.
        • et al.
        Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
        Arch Cardiovasc Dis. 2012; 105: 355-365
        • Dharmarajan K.
        • Masoudi F.A.
        • Spertus J.A.
        • Li S.X.
        • Krumholz H.M.
        Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure.
        JAMA Intern Med. 2013; 173: 1547-1549
        • Scrutinio D.
        • Passantino A.
        • Ricci V.A.
        • Catanzaro R.
        Association between conformity with performance measures and 1-year postdischarge survival in patients with acute decompensated heart failure.
        Am J Med Qual. 2013; 28: 160-168
        • van Veldhuisen D.J.
        • Cohen-Solal A.
        • Böhm M.
        • Anker S.D.
        • Babalis D.
        • Roughton M.
        • et al.
        Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of effects of nebivolol intervention on outcomes and rehospitalization in seniors with heart failure).
        J Am Coll Cardiol. 2009; 53: 2150-2158
        • Lund L.H.
        • Benson L.
        • Dahlström U.
        • Edner M.
        • Friberg L.
        Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
        JAMA. 2014; 312: 2008-2018
        • Liu F.
        • Chen Y.
        • Feng X.
        • Teng Z.
        • Yuan Y.
        • Bin J.
        Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis.
        PLoS One. 2014; 9e90555https://doi.org/10.1371/journal.pone.00905
        • Zheng S.L.
        • Chan F.T.
        • Nabeebaccus A.A.
        • Shah A.M.
        • McDonagh T.
        • Okonko D.O.
        • et al.
        Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
        Heart. 2018; 104: 407-415
        • El-Refai M.
        • Peterson E.L.
        • Wells K.
        • Swadia T.
        • Sabbah H.N.
        • Spertus J.A.
        • et al.
        Comparison of β-blocker effectiveness in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction.
        J Card Fail. 2013; 19: 73-79
        • Lipworth B.
        • Wedzicha J.
        • Devereux G.
        • Vestbo J.
        • Dransfield M.T.
        Beta-blockers in COPD: time for reappraisal.
        Eur Respir J. 2016; 48: 880-888
        • Salpeter S.R.
        • Ormiston T.M.
        • Salpeter E.E.
        • Poole P.J.
        • Cates C.J.
        Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
        Respir Med. 2003; 97: 1094-1101
        • Salpeter S.
        • Ormiston T.
        • Salpeter E.
        Cardioselective beta-blockers for chronic obstructive pulmonary disease.
        Cochrane Database Syst Rev. 2005; 4
        • Kotlyar E.
        • Keogh A.M.
        • Macdonald P.S.
        • Arnold R.H.
        • McCaffrey D.J.
        • Glanville A.R.
        Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
        J Heart Lung Transplant. 2002; 21: 1290-1295
        • Sirak T.E.
        • Jelic S.
        • Le Jemtel T.H.
        Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
        J Am Coll Cardiol. 2004; 44: 497-502
        • Vogelmeier C.F.
        • Criner G.J.
        • Martinez F.J.
        • Anzueto A.
        • Barnes P.J.
        • Bourbeau J.
        • et al.
        Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary.
        Eur Respir J. 2017; 49: 1700214https://doi.org/10.1183/13993003.00214-2017
        • Hawkins N.M.
        • Virani S.
        • Ceconi C.
        Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services.
        Eur Heart J. 2013; 34: 2795-2803
        • Hawkins N.M.
        • Petrie M.C.
        • Macdonald M.R.
        • Jhund P.S.
        • Fabbri L.M.
        • Wikstrand J.
        • et al.
        Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
        J Am Coll Cardiol. 2011; 57: 2127-2138